Adarsh Bhimraj MD FIDSA
abhimraj.bsky.social
Infectious diseases physician & educator | Neuro-ID | Evidence-based medicine & guideline methodology | COVID-19 therapeutics | Clinician well-being | Purpose, resilience & meaning in medicine
👤 Joined on 17 November 2024
21
Followers
47
Following
7
Total Posts
📜 Kullanıcı Geçmişi
- 17 Kas 2024, 19:12
🎉 Bluesky'e katıldı - İlk kullanıcı adı:
@abhimraj.bsky.social
🚫 Blokladığı Kullanıcılar
❤️ Beğendiği Gönderiler
On #IDSky, we love cephalexin, but is use is limited by its 4️⃣ times a day dosing. Cystitis has shown promise with 2️⃣ a day dosing. For cellulitis, there is promise at 3️⃣ times a day dosing. doi.org/10.1093/ofid...
Show Post
What happens when an antiviral works by causing mutations? In a new Let’s Talk ID episode, JID Deputy Editor Jonathan Li, MD, FIDSA talks the science behind molnupiravir and a recent paper that raised questions about its potential effects in mammalian cells. Watch: www.idsociety.org/multimedia/p...
Show Post
Neuro-ID needs more clinicians and researchers. 🧠🦠 CSF shunt infections are complex, & evidence is sparse. Our review bringf it together into practical guidance. Proud of the team, especially @ Nitin Das, and excited for his future in Neuro-ID! Article doi.org/10.1093/cid/...
Show PostJoin the next IDSA Foundation Bartlett webinar on Mon. Oct. 19 at 1pm ET to explore RSV prevention products and approaches to implementing monoclonal antibody prevention in birth hospital and outpatient settings, in partnership with @pidsociety.bsky.social. Register: https://bit.ly/4dSTJlt
Show Post